Nathan D. Hatton
( out of 38 reviews )

Nathan D. Hatton, MD

Languages spoken: English

Clinical Locations

Sugar House Health Center

Salt Lake City
801-581-2000

Cardiovascular Center

Cardiovascular Center
Salt Lake City
801-585-7676

  • Nathan D. Hatton, M.D. is a Professor of Medicine at the University of Utah School Of Medicine. He grew up in a small Indiana community before completing his undergraduate education at Hanover College. He subsequently attended Indiana University where he obtained a masters degree in physiology and biophysics prior to attending medical school. He received his medical degree from Indiana University prior to moving to Utah for his training in Internal Medicine at University Of Utah. He completed a Pulmonary Medicine and Critical Care Medicine fellowship at the University of Utah. Upon completion of his fellowship he joined the faculty at the University of Utah in 2009.

    He served as the Associate Medical Director of the Medical Intensive Care Unit at the University Hospital from 2012 to 2017. His current hospital based responsibilities include attending in the Medical Intensive Care Unit at University Hospital and focusing on housestaff and nursing education. His outpatient clinical care focuses on general pulmonary diseases along with patients with pulmonary hypertension. He is the co-director of the Pulmonary Hypertension Dyspnea Center at the University of Utah. He also has directed the second year medical student pulmonary medicine curriculum for the past decade. He has recently been promoted to the pulmonary core educator with in the University of Utah Medical school overseeing the entire four year pulmonary curriculum. Most recently, he has been an intricate part in the planning and management of the SARS-2-CoV pandemic at the University of Utah hospital. For this project, he has applied continuous critical care experience taking care of COVID19 patients since March 2020 to assist in study design. His experiences are most helpful in assessing key clinical annotations that may be helpful in understanding the plausibility of different biological pathways that underlie our deep clinical experience. For example, to consider how the different SARS-CoV-2 variants affect specific findings related to respiratory failure which may be plausible modifiers of biological pathways that underlie poor outcomes. Of course, he overseeing the collection of simultaneous upper airway and tracheal samples to enable the multiple laboratory measurements that make this project novel, compelling and generalizable.

    Specialties

    Board Certification

    American Board of Internal Medicine (Sub: Critical Care Medicine)
    American Board of Internal Medicine (Sub: Pulmonary Disease)

    Patient Rating

    5.0 /5
    ( out of 38 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    October 19, 2024
    UH HOSPITALS AND CLINICS

    Dr Hatton was quite personable and kind, as well as very knowledgeable. His suggestions for possible care included considering my own feelings about my care.

    October 17, 2024
    UH HOSPITALS AND CLINICS

    Dr Hatton was kind and caring.

    October 04, 2024
    UH HOSPITALS AND CLINICS

    Very nice and willingness to set goals for my future health.

    September 07, 2024
    SUGAR HOUSE HEALTH CENTER

    Very helpful in all aspects of my health and emotional wellbeing.

    July 03, 2024
    SUGAR HOUSE HEALTH CENTER

    After carefully reviewing all of my tests, Dr. Hatton was able to ease my concerns of a potentially devastating outcome which was ruled out. Together we discussed strategies moving forward.

    June 14, 2024
    SUGAR HOUSE HEALTH CENTER

    I was totally comfortable and felt his concern, skill and desire to help me feel better. I was ENCOURAGED

    June 11, 2024
    SUGAR HOUSE HEALTH CENTER

    Thank you for supporting my journey to figure out my health goals

    May 18, 2024
    SUGAR HOUSE HEALTH CENTER

    He was brilliant with the assessment of my condition, able to assess the data thoroughly for a solution and give me recommendations based on test results, symptoms and current meds. I feel like he really helped me manage my condition moving forward.

    May 14, 2024
    SUGAR HOUSE HEALTH CENTER

    Very complete video conference addressing all of the issues and questions regarding my health care. Very good at considering the patient's perspective regarding health care.

    See More Patient Comments

  • Nathan D. Hatton, M.D. is a Professor of Medicine at the University of Utah School Of Medicine. He grew up in a small Indiana community before completing his undergraduate education at Hanover College. He subsequently attended Indiana University where he obtained a masters degree in physiology and biophysics prior to attending medical school. He received his medical degree from Indiana University prior to moving to Utah for his training in Internal Medicine at University Of Utah. He completed a Pulmonary Medicine and Critical Care Medicine fellowship at the University of Utah. Upon completion of his fellowship he joined the faculty at the University of Utah in 2009.

    He served as the Associate Medical Director of the Medical Intensive Care Unit at the University Hospital from 2012 to 2017. His current hospital based responsibilities include attending in the Medical Intensive Care Unit at University Hospital and focusing on housestaff and nursing education. His outpatient clinical care focuses on general pulmonary diseases along with patients with pulmonary hypertension. He is the co-director of the Pulmonary Hypertension Dyspnea Center at the University of Utah. He also has directed the second year medical student pulmonary medicine curriculum for the past decade. He has recently been promoted to the pulmonary core educator with in the University of Utah Medical school overseeing the entire four year pulmonary curriculum. Most recently, he has been an intricate part in the planning and management of the SARS-2-CoV pandemic at the University of Utah hospital. For this project, he has applied continuous critical care experience taking care of COVID19 patients since March 2020 to assist in study design. His experiences are most helpful in assessing key clinical annotations that may be helpful in understanding the plausibility of different biological pathways that underlie our deep clinical experience. For example, to consider how the different SARS-CoV-2 variants affect specific findings related to respiratory failure which may be plausible modifiers of biological pathways that underlie poor outcomes. Of course, he overseeing the collection of simultaneous upper airway and tracheal samples to enable the multiple laboratory measurements that make this project novel, compelling and generalizable.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Public Health
    Board Certification
    American Board of Internal Medicine (Sub: Critical Care Medicine)
    American Board of Internal Medicine (Sub: Pulmonary Disease)

    Education history

    Fellowship Pulmonary/Critical Care - University of Utah School of Medicine Fellow
    Internal Medicine - University of Utah School of Medicine Resident
    Internship Internal Medicine - University of Utah School of Medicine Intern
    Medicine - Indiana University School of Medicine M.D.
    Graduate Training Physiology - Indiana University M.A.
    Biology - Hanover College B.A.

    Selected Publications

    Journal Article

    1. Ingram D, Alamri AK, Penn BA, Mayeux JD, Ma CL, Clapham KR, Abraham AE, Klanderud D, Sadeh B, Beck EM, Hatton ND, Ryan JJ (2022). Characteristics of Patients With Pulmonary Arterial Hypertension in a Pulmonary Hypertension Association-Accredited Comprehensive Care Center: A Contrast in Features When Compared With US National Registry Data. Cureus, 14(11), e31764. (Read full article)
    2. Tonna JE, Pierce J, Hatton N, Lewis G, Phillips JD, Messina A, Skidmore CR, Taylor K, Selzman CH (2021). Safety and feasibility of using acellular sterile filtered amniotic fluid as a treatment for patients with COVID-19: protocol for a randomised, double-blinded, placebo-controlled clinical trial. BMJ Open, 11(2), e045162. (Read full article)
    3. Selzman CH, Tonna JE, Pierce J, Vargas C, Skidmore C, Lewis G, Hatton ND, Phillips JD (2021). A pilot trial of human amniotic fluid for the treatment of COVID-19. BMC Res Notes, 14(1), 32. (Read full article)
    4. Mayeux JD, Pan IZ, Dechand J, Jacobs JA, Jones TL, McKellar SH, Beck E, Hatton ND, Ryan JJ (2020). Management of Pulmonary Arterial Hypertension. Curr Cardiovasc Risk Rep, 15(1), 2. (Read full article)
    5. Ciarkowski CE, Timbrook TT, Kukhareva PV, Edholm KM, Hatton ND, Hopkins CL, Thomas F, Sanford MN, Igumnova E, Benefield RJ, Kawamoto K, Spivak ES (2020). A Pathway for Community-Acquired Pneumonia With Rapid Conversion to Oral Therapy Improves Health Care Value. Open Forum Infect Dis, 7(11), ofaa497. (Read full article)
    6. Edholm K, Lapp K, Kukhareva P, Hopkins C, Hatton ND, Gebhart B, Nyman H, Signor E, Davis M, Kawamoto K, Johnson SA (2020). Reducing Diabetic Ketoacidosis Intensive Care Unit Admissions Through an Electronic Health Record-Driven, Standardized Care Pathway. J Healthc Qual, 42(5), e66-e74. (Read full article)
    7. Jin N, Hatton N, Swartz DR, Xia Xl, Harrington MA, Larsen SH, Rhoades RA (2000). Hypoxia activates jun-N-terminal kinase, extracellular signal-regulated protein kinase, and p38 kinase in pulmonary arteries. Am J Respir Cell Mol Biol, 23(5), 593-601. (Read full article)

    Review

    1. Tsarova K, Morgan AE, Melendres-Groves L, Ibrahim MM, Ma CL, Pan IZ, Hatton ND, Beck EM, Ferrel MN, Selzman CH, Ingram D, Alamri AK, Ratcliffe MB, Wilson BD, Ryan JJ (2022). Imaging in Pulmonary Vascular Disease-Understanding Right Ventricle-Pulmonary Artery Coupling. [Review]. Compr Physiol, 12(4), 3705-3730. (Read full article)

    Case Report

    1. Pan IZ, Carey JR, Jacobs JA, Dechand J, Sessions JJ, Sorensen T, Penn BA, Mayeux JD, Hatton ND, Ryan JJ (2020). Transitioning Between Prostanoid Therapies in Pulmonary Arterial Hypertension. Front Med (Lausanne), 7, 81. (Read full article)

    Editorial

    1. Gilbertson EA, Hatton ND, Ryan JJ (2020). Point of care ultrasound: the next evolution of medical education. Ann Transl Med, 8(14), 846. (Read full article)
    2. Beck EM, Hatton ND, Ryan JJ (2019). Novel techniques for advancing our understanding of pulmonary arterial hypertension. Eur Respir J, 53(5). (Read full article)

    Letter

    1. Liou TG, Adler FR, Hatton ND (2020). The Uncertain Role of Corticosteroids in the Treatment of COVID-19. [Letter to the editor]. JAMA Intern Med, 181(1), 139-140. (Read full article)